PharmaLinea acquired by ANJAC Health & Beauty Group

Ljubljana - PharmaLinea, a leading provider of clinically supported private label food supplements has announced its acquisition by ANJAC Health & Beauty, a French industrial group that now comprises 17 complementary companies with R&D and production capabilities in the fields of health, beauty, personal care and food supplements. The acquisition marks a new era of opportunity for PharmaLinea, reinforcing its growth trajectory and enabling access to new technologies, innovation possibilities, and partners.

ANJAC Health & Beauty, the partner of pharmaceutical laboratories and beauty and wellness brands

ANJAC Health & Beauty is a French family-owned industrial group specializing in the formulation, manufacturing and filling of cosmetics, medical devices, drugs, and food supplements. Integrating what is now 17 companies with 17 R&D sites and 24 manufacturing sites across Europe and North America, ANJAC creates, develops and manufactures raw materials to finished products. With the acquisition of Health Chain Group (HCG), composed of sister companies PharmaLinea, Hermes Consilium, and ErgoPharma, ANJAC follows its broader strategy to strengthen its health and pharma activities, particularly by expanding its nutrition and innovative food ingredients offering. The goal is to bridge food and supplementation to provide unique health solutions, backed with clinical studies. The acquisition also enhances ANJAC’s commercial presence in high-potential markets across Central and Eastern Europe, as well as in Asia, the Middle East, and North America. Founded in 2008, ANJAC Health & Beauty Group now has a consolidated workforce of over 3.300 and a 2025 turnover expected of nearly €800million, positioning it as a leading comprehensive R&D and production partner for pharmaceutical laboratories, beauty and wellness brands.

PharmaLinea and HCG, an evolution from ingredient distribution to vertical integration

From its beginnings as a single ingredient distribution company, HCG rapidly evolved into a diverse international player in the B2B nutraceutical space, present in over 40 markets worldwide. Its structure with three sister companies active across different segments of the nutraceutical industry and a vertically integrated model allows the group to control the entire value chain from ingredients to finished products. The group operates through three complementary entities:

• Hermes Consilium – a creator and distributor of high-quality, branded ingredients for nutritional products.

• PharmaLinea - an expert in the development of clinically supported private label food supplements, backed by clinical studies, patented ingredients and technologies, and offering scientific and marketing consulting services to clients.

• ErgoPharma – a state-of-the-art production unit for manufacturing, ensuring industrial performance and full traceability.

Led by PharmaLinea, HCG members have become widely recognized for their ingredients, technologies, products, and the robustness of their clinical evidence. In the latest step of their evolution, PharmaLinea and the entire HCG are becoming part of ANJAC Health & Beauty Group, which aligns perfectly with their innovative DNA and marks both a milestone of success and a beginning of a new chapter.

Synergies and shared vision of the future

The partnership between ANJAC and PharmaLinea opens new pathways for advancing product innovation, scientific research, and comprehensive service for client brands. PharmaLinea will retain its distinctive identity and dedication to the principles that have defined its success. It will continue to operate as a trusted partner to nutraceutical brands worldwide, while benefiting from ANJAC’s extensive infrastructure, cross-sector expertise, and R&D resources. As part of the ANJAC Group, PharmaLinea will be able to accelerate the development of high-value, clinically supported concepts and bring forward new formats and solutions that meet the evolving needs of health-conscious consumers.

Blaž Gorjup, Chairman & Founder of PharmaLinea: “PharmaLinea and Health Chain Group was founded with a simple yet ambitious goal: to bring more science, integrity, and trust to the nutraceutical industry. Seeing that vision grow into a group recognized across the world fills me with pride and gratitude. Joining forces with ANJAC will allow HCG to reach even higher while staying true to its values. It’s because of this strong foundation and bright outlook that I chose to remain a minority shareholder and continue to be available to the company as it moves forward. My sincere thanks go to everyone who has contributed to this journey.”

Anton Oražem, CEO of PharmaLinea: “This marks an incredibly exciting new chapter for PharmaLinea. Becoming part of ANJAC Health & Beauty represents both a great milestone and a strong confirmation of how far we’ve come — the culmination of many years of hard work in establishing our company, our processes, our network, and our product pipeline. We are truly proud to join such a renowned group that shares the same values, entrepreneurial DNA, and long-term vision for the future. With ANJAC’s extensive network across the health and beauty industries, PharmaLinea will gain access to new technologies, new innovation possibilities, and new partners — all of which will further strengthen our ability to deliver premium, clinically substantiated supplement solutions to our clients. This partnership opens an era of extraordinary opportunity. It will give wings to PharmaLinea’s story, while at the same time complementing and completing the offering that ANJAC provides to its partners worldwide. We are excited about the journey ahead and the value this collaboration will bring to both organizations.”

The acquisition of PharmaLinea and HCG marks a new growth driver for ANJAC in the food supplement market, enhancing its custom manufacturing and turnkey product offering while expanding its portfolio of proprietary patents and clinical studies. HCG’s strong marketing, scientific and regulatory expertise, particularly through PharmaLinea, will enable ANJAC to support its clients from product conception to market launch, combining consumer insights, global trends, and distinctive clinical validation. The commercial synergies between ANJAC and HCG will enhance international growth in the health and pharma segments, while also enabling the acceleration of PharmaLinea’s expertise to beauty-related applications with clinically proven efficiency—a strategic step toward ANJAC’s ambition to strengthen its global position in the nutraceutical market.

Aurélien Chaufour, President of the ANJAC Group: “We are delighted to welcome HCG to the ANJAC Group. This partnership reflects our strong ambitions in the health and pharma segment, our strategy in clinically backed food and nutraceuticals solutions and the continued acceleration of our international growth. We share with HCG a common vision: delivering innovative, high-performance solutions with a premium level of service recognized by our clients.”